Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

380 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ERBB family fusions are recurrent and actionable oncogenic targets across cancer types.
Schubert L, Elliott A, Le AT, Estrada-Bernal A, Doebele RC, Lou E, Borghaei H, Demeure MJ, Kurzrock R, Reuss JE, Ou SI, Braxton DR, Thomas CA, Darabi S, Korn WM, El-Deiry WS, Liu SV. Schubert L, et al. Among authors: thomas ca. Front Oncol. 2023 Apr 24;13:1115405. doi: 10.3389/fonc.2023.1115405. eCollection 2023. Front Oncol. 2023. PMID: 37168365 Free PMC article.
The Oncology Care Model: A Critique.
Thomas CA, Ward JC. Thomas CA, et al. Am Soc Clin Oncol Educ Book. 2016;35:e109-14. doi: 10.1200/EDBK_156883. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249711 Free article.
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial.
Reck M, Mok TSK, Nishio M, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, Rodríguez-Abreu D, Moro-Sibilot D, Thomas CA, Barlesi F, Finley G, Lee A, Coleman S, Deng Y, Kowanetz M, Shankar G, Lin W, Socinski MA; IMpower150 Study Group. Reck M, et al. Among authors: thomas ca. Lancet Respir Med. 2019 May;7(5):387-401. doi: 10.1016/S2213-2600(19)30084-0. Epub 2019 Mar 25. Lancet Respir Med. 2019. PMID: 30922878 Clinical Trial.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Community oncologists' perceptions and utilization of large-panel genomic tumor testing.
Anderson EC, Hinton AC, Lary CW, Fenton ATHR, Antov A, Edelman E, Helbig P, Reed K, Miesfeldt S, Thomas CA, Hall MJ, Roberts JS, Rueter J, Han PKJ; MCGI Working Group. Anderson EC, et al. Among authors: thomas ca. BMC Cancer. 2021 Nov 25;21(1):1273. doi: 10.1186/s12885-021-08985-0. BMC Cancer. 2021. PMID: 34823486 Free PMC article.
Persistent Hot-Spot Mix in Cryogenic Direct-Drive Fusion Experiments.
Shah RC, Cao D, Igumenshchev IV, Goncharov VN, Anderson KS, Bauer KA, Betti R, Bonino MJ, Campbell EM, Colaïtis A, Collins TJB, Churnetski K, Forrest CJ, Froula DH, Glebov VY, Gopalaswamy V, Harding DR, Hu SX, Janezic RT, Kwiatkowski J, Lees A, Morse SFB, Miller S, Patel D, Regan SP, Sampat S, Thomas CA, Turnbull D. Shah RC, et al. Among authors: thomas ca. Phys Rev Lett. 2024 Aug 30;133(9):095101. doi: 10.1103/PhysRevLett.133.095101. Phys Rev Lett. 2024. PMID: 39270173
Restoring susceptibility to β-lactam antibiotics in methicillin-resistant Staphylococcus aureus.
Nguyen VT, Birhanu BT, Miguel-Ruano V, Kim C, Batuecas M, Yang J, El-Araby AM, Jiménez-Faraco E, Schroeder VA, Alba A, Rana N, Sader S, Thomas CA, Feltzer R, Lee M, Fisher JF, Hermoso JA, Chang M, Mobashery S. Nguyen VT, et al. Among authors: thomas ca. Nat Chem Biol. 2024 Jul 26. doi: 10.1038/s41589-024-01688-0. Online ahead of print. Nat Chem Biol. 2024. PMID: 39060390
Mechanism of an animal toxin-antidote system.
Caro L, Wei AD, Thomas CA, Posch G, Uremis A, Franzi MC, Abell SJ, Laszlo AH, Gundlach JH, Ramirez JM, Ailion M. Caro L, et al. Among authors: thomas ca. bioRxiv [Preprint]. 2024 Jun 13:2024.06.11.598564. doi: 10.1101/2024.06.11.598564. bioRxiv. 2024. PMID: 38915716 Free PMC article. Preprint.
380 results